VIPS [Vipshop] 6-K: (Original Filing)
[001-35454 Vipshop Holdings Limited No. 20 Huahai Street Liwan District, Guangzhou 510370 Peoples Republic of China Form 20-F x o o o Appointment of New Chief Technology Officer 2 Vipshop Holdings Limited]
[001-35454 Vipshop Holdings Limited No. 20 Huahai Street Liwan District, Guangzhou 510370 Peoples Republic of China Form 20-F x o o o Appointment of New Chief Technology Officer 2 Vipshop Holdings Limited]
[001-35454 Vipshop Holdings Limited No. 20 Huahai Street Liwan District, Guangzhou 510370 Peoples Republic of China Form 20-F x o o o Appointment of New Chief Technology Officer 2 Vipshop Holdings Limited]
[Securities Purchase Agreement This Securities Purchase Agreement Agreement China Recycling Energy Corporation Company Iliad Research and Trading, L.P. Investor Party Parties (this “ 1933 Act SEC Note Common Stock B. Investor desires to purchase and Company desires to issue and sell, upon the terms a]
[Securities Purchase Agreement This Securities Purchase Agreement Agreement China Recycling Energy Corporation Company Iliad Research and Trading, L.P. Investor Party Parties (this “ 1933 Act SEC Note Common Stock B. Investor desires to purchase and Company desires to issue and sell, upon the terms a]
[Number 1.1 Notice of the Annual General Meeting, dated April 12, 2019 2.1 Circular, dated April 12, 2019 • our business objectives and strategies, including those relating to the development of our terminal procurement and distribution business; • our operations and prospects; • our network expansio]
[Number 1.1 Notice of the Annual General Meeting, dated April 12, 2019 2.1 Circular, dated April 12, 2019 • our business objectives and strategies, including those relating to the development of our terminal procurement and distribution business; • our operations and prospects; • our network expansio]
[Sinovac Update on the Exchange of Rights for Common and Series B Preferred Shares April 12, 2019 05:04 PM Eastern Daylight Time BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ:SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, today provided an updat]
[Sinovac Update on the Exchange of Rights for Common and Series B Preferred Shares April 12, 2019 05:04 PM Eastern Daylight Time BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ:SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, today provided an updat]